Schedule 13G ownership disclosure

Dyne Therapeutics Inc

Common Stock · CUSIP: 26818M108

Event date: 2024-12-31

Filing-level shares
7,379,309
Percent of class
7.3%
  • JANUS HENDERSON GROUP PLC

    Shares: 7,379,309 · Class: 7.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-25-000075
Form type
SCHEDULE 13G/A
Filer
Dyne Therapeutics, Inc.
CIK
CIK 1818794
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub